Aristopharma, one of the leading pharmaceutical companies of Bangladesh got international acknowledgment for its product named Omep-20 (Omeprazol capsul), says a press release.
A Bioequivalence trial was conducted in 2008 to compare the bio-availability and pharmacokinetic profile of Omep-20 with the research product of AstraZeneca, Losec and it showed that both has same rate and extent of drug absorption.
The trial report was evaluated and accepted by editorial board of German Medical Journal-Arzneimittel-forchung /Drug Research.
Source: The Daily Star, July 25, 2009
Leave a Reply